Paul L. Berns - Jun 23, 2023 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Director
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Paul L. Berns
Stock symbol
UBX
Transactions as of
Jun 23, 2023
Transactions value $
$0
Form type
4
Date filed
6/26/2023, 05:12 PM
Previous filing
Jan 4, 2023
Next filing
Sep 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBX Stock Option (Right to Buy) Award $0 +6K $0.00 6K Jun 23, 2023 Common Stock 6K $3.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 23, 2023 or (ii) the date of the 2024 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.